United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Pharma Industry News PharmaJet and Immuno Cure partner to launch needle-free HIV therapeutic DNA vaccine trial using Tropis intradermal device PharmaJet and Immuno Cure sign agreement to use the Tropis intradermal system in a needle-free human trial for a promising HIV DNA vaccine candidate. byPallavi MadhirajuJune 23, 2025